DOCSLIB.ORG

Holdings KL Allocation Fund, As of 3/31/20

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Holdings KL Allocation Fund, As of 3/31/20 Holdings KL Allocation Fund, as of 3/31/20 Equity Securities % of Net Assets Country Sector CHUGAI PHARM CO 2.33 Japan Health Care FISHER & PAYKEL HE 1.79 New Zealand Health Care L'OREAL 1.72 France Consumer Staples COLOPLAST A/S 1.53 Denmark Health Care KONINKLIJKE DSM NV 1.44 Netherlands Materials INTEL CORP COM 1.13 United States Information Technology STERICYCLE INC 1.08 United States Industrials KAO CORP 1.08 Japan Consumer Staples SMC CORP 1.08 Japan Industrials UNI-CHARM CORP. 1.08 Japan Consumer Staples BIO-TECHNE CORP 1.07 United States Health Care DAIICHI SANKYO COM 1.06 Japan Health Care NOVARTIS AG 1.05 Switzerland Health Care GENTEX CORP 1.05 United States Consumer Discretionary JOHNSON & JOHNSON 1.04 United States Health Care 3M CO COM 1.04 United States Industrials SHIMADZU CORP 1.04 Japan Information Technology ALPHABET INC CAP STK CL A 1.04 United States Communication Services MERCK & CO INC COM 1.03 United States Health Care HISAMITSU PHARM CO 1.03 Japan Health Care PROCTER AND GAMBLE CO COM 1.03 United States Consumer Staples NISSIN FOOD HOLDINGS CO LTD 1.02 Japan Consumer Staples IROBOT CORP 1.01 United States Consumer Discretionary DAIKIN INDUSTRIES LTD 1.01 Japan Industrials NTT DOCOMO 1.00 Japan Communication Services GRIFOLS SA 1.00 Spain Health Care AIR LIQUIDE S.A. 1.00 France Materials BECTON DICKINSON & CO COM 1.00 United States Health Care NICE SYSTEMS LTD 0.99 Israel Information Technology VARIAN MED SYS INC COM 0.99 United States Health Care SYMRISE AG 0.98 Denmark Materials RECKITT BENCK GRP 0.98 United Kingdom Consumer Staples SUNTORY BEVERAGE & FOOD LTD 0.97 Japan Consumer Staples NOVO NORDISK A/S-B 0.94 Denmark Health Care SCHNEIDER ELECTRIC S.A. 0.89 France Industrials FRANCO NEVADA CORP 0.87 Canada Materials SWEDISH ORPHAN BIO 0.87 Sweden Health Care ROYAL GOLD INC 0.87 United States Materials ELISA OYJ 0.86 Finland Communication Services HOYA CORP 0.85 Japan Health Care CAE INC (CANADA) 0.84 Canada Industrials HARMONIC DRIVE SYS 0.82 Japan Industrials DANAHER CORP DEL COM 0.79 United States Health Care ASTELLAS PHARMA 0.79 Japan Health Care ADVANTEST CORP 0.78 Japan Information Technology SANOFI 0.77 France Health Care RINNAI CORP 0.77 Japan Consumer Discretionary HERMES INTL 0.76 France Consumer Discretionary NIPPON SHINYAKU CO 0.76 Japan Health Care FUJIFILM HOLDINGS CORP 0.72 Japan Information Technology ASTRAZENECA PLC 0.72 United Kingdom Health Care ABBOTT LABS COM 0.67 United States Health Care GLORY LTD 0.67 Japan Industrials MOWI ASA 0.64 Norway Consumer Staples SMITH & NEPHEW PLC 0.60 United Kingdom Health Care SONOVA HOLDING AG 0.60 Switzerland Health Care SMITHS GROUP 0.60 United Kingdom Industrials STRYKER CORP COM 0.58 United States Health Care TELE2 AB 0.56 Sweden Communication Services HELLA GMBH & CO.KG 0.47 Germany Consumer Discretionary MEGGITT PLC 0.38 United Kingdom Industrials Fixed Income % of Net Assets Country SCHWAB US TIPS ETF 5.52 United States ISHARES US TREAS 0-1YR USD A ETF 5.24 United States Precious Metals SPROTT PHYSICAL GOLD TRUST UNIT 9.29 Canada Cash Holdings United States Dollar 21.88 United States Portfolio composition will change due to ongoing management of the Fund. References to specific securities or sectors should not be construed as recommendations by the Fund, its Advisor or Distributor. The KL Allocation Fund is distributed by IMST Distributors, LLC. Please consider the Fund’s investment objectives, risks, charges and expenses before investing. The prospectus or summary prospectus that contains this and other information about the Fund, is available by calling 888.998.9890 and should be read carefully. When current market, economic, political or other conditions are unsuitable and would impair the pursuit of the Fund's investment objective, the Fund may temporarily invest its assets in cash or high-quality short-term money market instruments. When the Fund takes a temporary defensive position, it may not achieve its investment objective. The risk country was used for the country specification..
Load more

Recommended publications
  • View a Copy of This Licence, Visit Tivecommons.Org/Licenses/By/4.0
    Katakami et al. Cardiovasc Diabetol (2020) 19:110 https://doi.org/10.1186/s12933-020-01079-4 Cardiovascular Diabetology ORIGINAL INVESTIGATION Open Access Tofoglifozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study Naoto Katakami1,2* , Tomoya Mita3, Hidenori Yoshii4, Toshihiko Shiraiwa5, Tetsuyuki Yasuda6, Yosuke Okada7, Keiichi Torimoto7, Yutaka Umayahara8, Hideaki Kaneto9, Takeshi Osonoi10, Tsunehiko Yamamoto11, Nobuichi Kuribayashi12, Kazuhisa Maeda13, Hiroki Yokoyama14, Keisuke Kosugi15, Kentaro Ohtoshi16, Isao Hayashi17, Satoru Sumitani18, Mamiko Tsugawa19, Kayoko Ryomoto20, Hideki Taki21, Tadashi Nakamura22, Satoshi Kawashima23, Yasunori Sato24, Hirotaka Watada3 and Iichiro Shimomura1 on behalf of the UTOPIA study investigators Abstract Background: This study aimed to investigate the preventive efects of tofoglifozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, on atherosclerosis progression in type 2 diabetes (T2DM) patients without apparent cardiovascular disease (CVD) by monitoring carotid intima-media thickness (IMT). Methods: This prospective, randomized, open-label, blinded-endpoint, multicenter, parallel-group, comparative study included 340 subjects with T2DM and no history of apparent CVD recruited at 24 clinical units. Subjects were randomly allocated to either the tofoglifozin treatment group (n 169) or conventional treatment group using drugs other than SGLT2 inhibitors (n 171). Primary outcomes were changes= in mean and maximum common carotid IMT measured by echography during= a 104-week treatment period. Results: In a mixed-efects model for repeated measures, the mean IMT of the common carotid artery (mean- IMT-CCA), along with the right and left maximum IMT of the CCA (max-IMT-CCA), signifcantly declined in both the tofoglifozin ( 0.132 mm, SE 0.007; 0.163 mm, SE 0.013; 0.170 mm, SE 0.020, respectively) and the control group ( 0.140 mm,− SE 0.006; 0.190 mm,− SE 0.012; 0.190 mm,− SE 0.020, respectively).
    [Show full text]
  • FTSE Japan ESG Low Carbon Select
    2 FTSE Russell Publications 19 August 2021 FTSE Japan ESG Low Carbon Select Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country ABC-Mart 0.01 JAPAN Ebara 0.17 JAPAN JFE Holdings 0.04 JAPAN Acom 0.02 JAPAN Eisai 1.03 JAPAN JGC Corp 0.02 JAPAN Activia Properties 0.01 JAPAN Eneos Holdings 0.05 JAPAN JSR Corp 0.11 JAPAN Advance Residence Investment 0.01 JAPAN Ezaki Glico 0.01 JAPAN JTEKT 0.07 JAPAN Advantest Corp 0.53 JAPAN Fancl Corp 0.03 JAPAN Justsystems 0.01 JAPAN Aeon 0.61 JAPAN Fanuc 0.87 JAPAN Kagome 0.02 JAPAN AEON Financial Service 0.01 JAPAN Fast Retailing 3.13 JAPAN Kajima Corp 0.1 JAPAN Aeon Mall 0.01 JAPAN FP Corporation 0.04 JAPAN Kakaku.com Inc. 0.05 JAPAN AGC 0.06 JAPAN Fuji Electric 0.18 JAPAN Kaken Pharmaceutical 0.01 JAPAN Aica Kogyo 0.07 JAPAN Fuji Oil Holdings 0.01 JAPAN Kamigumi 0.01 JAPAN Ain Pharmaciez <0.005 JAPAN FUJIFILM Holdings 1.05 JAPAN Kaneka Corp 0.01 JAPAN Air Water 0.01 JAPAN Fujitsu 2.04 JAPAN Kansai Paint 0.05 JAPAN Aisin Seiki Co 0.31 JAPAN Fujitsu General 0.01 JAPAN Kao 1.38 JAPAN Ajinomoto Co 0.27 JAPAN Fukuoka Financial Group 0.01 JAPAN KDDI Corp 2.22 JAPAN Alfresa Holdings 0.01 JAPAN Fukuyama Transporting 0.01 JAPAN Keihan Holdings 0.02 JAPAN Alps Alpine 0.04 JAPAN Furukawa Electric 0.03 JAPAN Keikyu Corporation 0.02 JAPAN Amada 0.01 JAPAN Fuyo General Lease 0.08 JAPAN Keio Corp 0.04 JAPAN Amano Corp 0.01 JAPAN GLP J-REIT 0.02 JAPAN Keisei Electric Railway 0.03 JAPAN ANA Holdings 0.02 JAPAN GMO Internet 0.01 JAPAN Kenedix Office Investment Corporation 0.01 JAPAN Anritsu 0.15 JAPAN GMO Payment Gateway 0.01 JAPAN KEWPIE Corporation 0.03 JAPAN Aozora Bank 0.02 JAPAN Goldwin 0.01 JAPAN Keyence Corp 0.42 JAPAN As One 0.01 JAPAN GS Yuasa Corp 0.03 JAPAN Kikkoman 0.25 JAPAN Asahi Group Holdings 0.5 JAPAN GungHo Online Entertainment 0.01 JAPAN Kinden <0.005 JAPAN Asahi Intecc 0.01 JAPAN Gunma Bank 0.01 JAPAN Kintetsu 0.03 JAPAN Asahi Kasei Corporation 0.26 JAPAN H.U.
    [Show full text]
  • Mass Spectrometer Business Presentation Materials
    Mass Spectrometer Business Presentation Materials Hiroto Itoi, Corporate Officer Deputy General Manager of the Analytical & Measuring Instruments Division Shimadzu Corporation Jul. 3, 2018 Contents I. Introduction • Expansion of Mass Spectrometry ………………………………………………………………… p.3 • History of Shimadzu's Growth in Mass Spectrometry …………………………………………… p.5 II. Overview of Mass Spectrometers • Operating Principle, Demand Trends, and Vendors ……………………………………………… p.9 • Mass Spectra ………………………………………………………………………………………… p.10 • Configuration of Mass Spectrometers …………………………………………………………… p.11 • Ionization …………………………………………………………………………………………… p.12 • Mass Separation …………………………………………………………………………………… p.14 III. Shimadzu's Mass Spectrometer Business • Product Type ………………………………………………………………………………………… p.17 • Application Software ………………………………………………………………………………… p.18 • Growth Strategy for Mass Spectrometer Business ……………………………………………… p.19 • Expand/Improve Product Lines …………………………………………………………………… p.20 • Measures to Expand Application Fields …………………………………………………………… p.24 • Measures to Automate Data Processing Using AI ……………………………………………… p.25 IV. Summary • Future Direction ……………………………………………………………………………………… p.26 July 2018 Mass Spectrometer Business Presentation Materials 2 I. Introduction Expansion of Mass Spectrometry (1) Why Mass Spectrometry? Mass spectrometry is able to analyze a wide variety of compounds with high accuracy and high efficiency (simultaneous multicomponent analysis). It offers superior characteristics that are especially beneficial in the following fields,
    [Show full text]
  • Published on 7 October 2016 1. Constituents Change the Result Of
    The result of periodic review and component stocks of TOPIX Composite 1500(effective 31 October 2016) Published on 7 October 2016 1. Constituents Change Addition( 70 ) Deletion( 60 ) Code Issue Code Issue 1810 MATSUI CONSTRUCTION CO.,LTD. 1868 Mitsui Home Co.,Ltd. 1972 SANKO METAL INDUSTRIAL CO.,LTD. 2196 ESCRIT INC. 2117 Nissin Sugar Co.,Ltd. 2198 IKK Inc. 2124 JAC Recruitment Co.,Ltd. 2418 TSUKADA GLOBAL HOLDINGS Inc. 2170 Link and Motivation Inc. 3079 DVx Inc. 2337 Ichigo Inc. 3093 Treasure Factory Co.,LTD. 2359 CORE CORPORATION 3194 KIRINDO HOLDINGS CO.,LTD. 2429 WORLD HOLDINGS CO.,LTD. 3205 DAIDOH LIMITED 2462 J-COM Holdings Co.,Ltd. 3667 enish,inc. 2485 TEAR Corporation 3834 ASAHI Net,Inc. 2492 Infomart Corporation 3946 TOMOKU CO.,LTD. 2915 KENKO Mayonnaise Co.,Ltd. 4221 Okura Industrial Co.,Ltd. 3179 Syuppin Co.,Ltd. 4238 Miraial Co.,Ltd. 3193 Torikizoku co.,ltd. 4331 TAKE AND GIVE. NEEDS Co.,Ltd. 3196 HOTLAND Co.,Ltd. 4406 New Japan Chemical Co.,Ltd. 3199 Watahan & Co.,Ltd. 4538 Fuso Pharmaceutical Industries,Ltd. 3244 Samty Co.,Ltd. 4550 Nissui Pharmaceutical Co.,Ltd. 3250 A.D.Works Co.,Ltd. 4636 T&K TOKA CO.,LTD. 3543 KOMEDA Holdings Co.,Ltd. 4651 SANIX INCORPORATED 3636 Mitsubishi Research Institute,Inc. 4809 Paraca Inc. 3654 HITO-Communications,Inc. 5204 ISHIZUKA GLASS CO.,LTD. 3666 TECNOS JAPAN INCORPORATED 5998 Advanex Inc. 3678 MEDIA DO Co.,Ltd. 6203 Howa Machinery,Ltd. 3688 VOYAGE GROUP,INC. 6319 SNT CORPORATION 3694 OPTiM CORPORATION 6362 Ishii Iron Works Co.,Ltd. 3724 VeriServe Corporation 6373 DAIDO KOGYO CO.,LTD. 3765 GungHo Online Entertainment,Inc.
    [Show full text]
  • Ranking of Stocks by Market Capitalization(As of End of Mar.2020)
    Ranking of Stocks by Market Capitalization(As of End of Mar.2020) 1st Section Rank Code Issue Market Capitalization \100mil. 1 7203 TOYOTA MOTOR CORPORATION 212,127 2 9437 NTT DOCOMO,INC. 112,630 3 6861 KEYENCE CORPORATION 84,709 4 6758 SONY CORPORATION 81,786 5 9984 SoftBank Group Corp. 79,162 6 9433 KDDI CORPORATION 75,136 7 4519 CHUGAI PHARMACEUTICAL CO.,LTD. 69,960 8 9432 NIPPON TELEGRAPH AND TELEPHONE CORPORATION 68,006 9 9434 SoftBank Corp. 65,799 10 7974 Nintendo Co.,Ltd. 54,787 11 8306 Mitsubishi UFJ Financial Group,Inc. 54,735 12 4568 DAIICHI SANKYO COMPANY,LIMITED 52,707 13 4502 Takeda Pharmaceutical Company Limited 52,146 14 4661 ORIENTAL LAND CO.,LTD. 50,261 15 6098 Recruit Holdings Co.,Ltd. 47,419 16 9983 FAST RETAILING CO.,LTD. 46,873 17 7182 JAPAN POST BANK Co.,Ltd. 44,865 18 4063 Shin-Etsu Chemical Co.,Ltd. 44,707 19 7267 HONDA MOTOR CO.,LTD. 44,017 20 4452 Kao Corporation 42,560 21 6367 DAIKIN INDUSTRIES,LTD. 38,603 22 6981 Murata Manufacturing Co.,Ltd. 36,980 23 8058 Mitsubishi Corporation 36,436 24 8316 Sumitomo Mitsui Financial Group,Inc. 36,018 25 9022 Central Japan Railway Company 35,679 26 8001 ITOCHU Corporation 35,541 27 8766 Tokio Marine Holdings,Inc. 35,145 28 7741 HOYA CORPORATION 34,808 29 6594 NIDEC CORPORATION 33,433 30 8035 Tokyo Electron Limited 32,000 31 3382 Seven & I Holdings Co.,Ltd. 31,699 32 7751 CANON INC. 31,463 33 8411 Mizuho Financial Group,Inc.
    [Show full text]
  • Press Release
    Press Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Sunao Manabe, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Junichi Onuma, Vice President, Corporate Communications Department Telephone: +81-3-6225-1126 https://www.daiichisankyo.com Daiichi Sankyo Announces Transfer from Astellas Pharma of Three Products in Asia Tokyo, Japan (October 15, 2019) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it agreed with Astellas Pharma Inc. (hereafter, Astellas Pharma) that Astellas Pharma local subsidiaries companies in six Asian countries will transfer three products to Daiichi Sankyo. The products to be transferred and the countries where they are sold are as follows. Product Korea China Taiwan Thailand Philippines Indonesia [generic name (brand name)] Ramosetron Antiemetic ○ ○ ○ ○ (Nasea) Nicardipine Anti- ○ ○ ○ (Perdipine) hypertensive Barnidipine Anti- ○ (Oldeca) hypertensive ○ indicate the countries where the products are sold The antiemetics are expected to have synergistic effects with mirogabalin and the cancer drugs that Daiichi Sankyo is currently developing in Asia, and the two antihypertensives are expected to effectively utilize Daiichi Sankyo’s current infrastructures in combination with its cardiovascular products, such as olmesartan and edoxaban. The total net sales of Astellas Pharma's three products in fiscal year 2018 were approximately 5.0 billion yen. 1 Daiichi Sankyo will take over the rights
    [Show full text]
  • C054-E076 up Series
    C054-E076 UniBloc Performance Balances UP Series 836HULHV 8QL%ORFū 3HUIRUPDQFH%DODQFHV Superior Response Signicantly Increases Weighing Efciency +LJK6SHHG The display response time for weighing minute quantities (from about ten times the minimum display value) is about one second. That signicantly improves weighing efciency. 7RXJKQHVV Using the highly impact-resistant UniBloc sensor minimizes downtime due to malfunctions. 6WUHVV)UHH The STABLO™-AP ionizer (optional) eliminates static electricity effects to provide highly reliable measurements without any time-consuming steps. Large Pan with 0.01 g Large Pan with 0.1 g Minimum Display Value Minimum Display Value • UP2202X • UP2202Y • UP4201X • UP4201Y • UP4202X • UP4202Y • UP8201X • UP8201Y • UP6202X • UP6202Y Movie that explains UP-series features in easy-to-understand terms. https://www.shimadzu.com/an/balance/analytical/up-6.html Small Pan with 0.001 g Small Pan with 0.01 g Minimum Display Value Minimum Display Value • UP223X • UP223Y • UP423X • UP423Y • UP422X • UP422Y • UP623X • UP623Y • UP823X • UP823Y • UP822X • UP822Y • UP1023X • UP1023Y +LJK6SHHG High-speed weighing signicantly improves efciency of weighing operations. Signicantly Improved Response Provides Fastest Response Performance in Its Class Advanced digital control technology shortens display response times to about one ninth of previous values when weighing minute quantities, which signicantly improves work efciency. Response for Weighing Minute Quantities Large pan model with 0.01 g minimum display value Small pan model with 0.001 g minimum display value Previous 9 model 9× UP 1 Speedy Faster Response (vs. previous Shimadzu model) 0246810 Time (sec.) Measurement Conditions: Large pan model with 0.01 g minimum display value and 0.1 g load Small pan model with 0.001 g minimum display value and 0.01 g load UP-Wind Break (large pan windbreak) (only for large pan models with 0.01 g minimum display value) Newly designed UP-Wind Break included standard.
    [Show full text]
  • Proposal of a Data Processing Guideline for Realizing Automatic Measurement Process with General Geometrical Tolerances and Contactless Laser Scanning
    Proposal of a data processing guideline for realizing automatic measurement process with general geometrical tolerances and contactless laser scanning 2018/4/4 Atsuto Soma Hiromasa Suzuki Toshiaki Takahashi Copyright (c)2014, Japan Electronics and Information Technology Industries Association, All rights reserved. 1 Contents • Introduction of the Project • Problem Statements • Proposed Solution – Proposal of New General Geometric Tolerance (GGT) – Data Processing Guidelines for point cloud • Next Steps Copyright (c)2014, Japan Electronics and Information Technology Industries Association, All rights reserved. 2 Contents • Introduction of the Project • Problem Statements • Proposed Solution – Proposal of New General Geometric Tolerance (GGT) – Data Processing Guidelines for Point Cloud • Next Steps Copyright (c)2014, Japan Electronics and Information Technology Industries Association, All rights reserved. 3 Introduction of JEITA What is JEITA? The objective of the Japan Electronics and Information Technology Industries Association (JEITA) is to promote healthy manufacturing, international trade and consumption of electronics products and components in order to contribute to the overall development of the electronics and information technology (IT) industries, and thereby to promote further Japan's economic development and cultural prosperity. JEITA’s Policy and Strategy Board > Number of full members: 279> Number of associate members: 117(as of May 13, 2014) - Director companies and chair/subchair companies - Policy director companies (alphabetical) Fujitsu Limited (chairman Masami Yamamoto) Asahi Glass Co., Ltd. Nichicon Corporation Sharp Corporation Azbil Corporation IBM Japan, Ltd. Hitachi, Ltd. Advantest Corporation Nippon Chemi-Con Corporation Panasonic Corporation Ikegami Tsushinki Co., Ltd. Japan Aviation Electronics Industry, Ltd. SMK Corporation Mitsubishi Electric Corporation Nihon Kohden Corporation Omron Corporation NEC Corporation JRC Nihon Musen Kyocera Corporation Sony Corporation Hitachi Metals, Ltd KOA Corporation Fuji Xerox Co., Ltd.
    [Show full text]
  • Facilitation of Information Transfer on Chemicals in Products
    Facilitation of Information Transfer on Chemicals in Products The Ministry of Economy, Trade and Industry (METI) developed ‘chemSHERPA’ [kémʃéərpə] as a new information transfer scheme for chemicals in products throughout their supply chains. METI hopes that the dissemination of chemSHERPA may contribute to reduce the workload of both providers and recipients of the information. From the beginning of the development of chemSHERPA, METI has been in communication with international bodies such as the IEC and the IPC, etc., with the aim of developing chemSHERPA into not only a Japanese standard but also an International standard. To make it a de-facto standard, METI has introduced this scheme to international organizations and governments of other countries for their active use. The Joint Article Management Promotion Consortium (JAMP) is a governing body for chemSHERPA from April 2016 and see a shift to chemSHERPA. We believe many companies are preparing towards implementing chemSHERPA. Based on the efforts mentioned above, the following companies and company groups have agreed with the dissemination of chemSHERPA, and METI will continue to work with JAMP and companies to spread the use of chemSHERPA to internal as well as external supply chains as needed.(Please contact us if any company or company group has interest in putting its name below.) It should be noted, the use of the provision of data entry support tools is free of charge in principle with the aim of promoting wider use of chemSHERPA. [Contact information] Chemical Management Policy Division Manufacturing Industries Bureau Ministry of Economy, Trade and Industry [email protected] 03-3501-0080 (direct) 03-3501-1511 (ex.
    [Show full text]
  • Facilitation of Information Transfer on Chemicals in Products
    Facilitation of Information Transfer on Chemicals in Products The Ministry of Economy, Trade and Industry (METI) has developed ‘chemSHERPA’ [kémʃéərpə] as a new information transfer scheme for chemicals in products throughout their supply chains. METI hopes that the dissemination of chemSHERPA may contribute to reduce the workload of both providers and recipients of the information. From the beginning of the development of chemSHERPA, METI has been in communication with international bodies such as the IEC and the IPC, etc., with the aim of developing chemSHERPA into not only a Japanese standard but also an International standard. To make it a de-facto standard, METI has introduced this scheme to international organizations and governments of other countries for their active use. The Joint Article Management Promotion Consortium (JAMP) will be a governing body for chemSHERPA from April 2016 and METI expects to see an orderly, step-by-step shift to chemSHERPA over the two years transition period. Accordingly JAMP has a plan to finish renewing the substances list in the existing JAMP scheme by the end of March of 2018. We believe many companies will begin advance preparations towards implementing chemSHERPA. Based on the efforts mentioned above, the following companies and company groups have agreed with the dissemination of chemSHERPA, and METI will continue to work with companies to spread the use of chemSHERPA to internal as well as external supply chains.(Please contact us if any company or company group has interest in putting its name below.) It should be noted, the use of the provision of data entry support tools is free of charge in principle with the aim of promoting wider use of chemSHERPA.
    [Show full text]
  • R&Co Risk-Based International Index – Weighting
    Rothschild & Co Risk-Based International Index Indicative Index Weight Data as of June 30, 2021 on close Constituent Exchange Country Index Weight(%) Jardine Matheson Holdings Ltd Singapore 1.46 LEG Immobilien SE Germany 0.98 Ajinomoto Co Inc Japan 0.95 SoftBank Corp Japan 0.89 Shimano Inc Japan 0.85 FUJIFILM Holdings Corp Japan 0.73 Singapore Exchange Ltd Singapore 0.72 Japan Tobacco Inc Japan 0.72 Cellnex Telecom SA Spain 0.69 Nintendo Co Ltd Japan 0.69 Carrefour SA France 0.67 Nexon Co Ltd Japan 0.66 Deutsche Wohnen SE Germany 0.65 Bank of China Ltd Hong Kong 0.64 REN - Redes Energeticas Nacion Portugal 0.63 Pan Pacific International Hold Japan 0.63 Japan Post Holdings Co Ltd Japan 0.62 Nippon Telegraph & Telephone C Japan 0.61 Roche Holding AG Switzerland 0.61 Nestle SA Switzerland 0.61 Novo Nordisk A/S Denmark 0.59 ENEOS Holdings Inc Japan 0.59 Nomura Research Institute Ltd Japan 0.59 Koninklijke Ahold Delhaize NV Netherlands 0.59 Jeronimo Martins SGPS SA Portugal 0.58 HelloFresh SE Germany 0.58 Toshiba Corp Japan 0.58 Hoya Corp Japan 0.58 Siemens Healthineers AG Germany 0.58 MS&AD Insurance Group Holdings Japan 0.57 Coloplast A/S Denmark 0.57 Kerry Group PLC Ireland 0.57 Scout24 AG Germany 0.57 SG Holdings Co Ltd Japan 0.56 Symrise AG Germany 0.56 Nitori Holdings Co Ltd Japan 0.56 Beiersdorf AG Germany 0.55 Mitsubishi Corp Japan 0.55 KDDI Corp Japan 0.55 Sysmex Corp Japan 0.55 Chr Hansen Holding A/S Denmark 0.55 Ping An Insurance Group Co of Hong Kong 0.55 Eisai Co Ltd Japan 0.54 Chocoladefabriken Lindt & Spru Switzerland 0.54 Givaudan
    [Show full text]
  • Association Between Variability in Body Mass Index and Development of Type 2 Diabetes: Panasonic Cohort Study
    Epidemiology/Health services research Open access Original research BMJ Open Diab Res Care: first published as 10.1136/bmjdrc-2021-002123 on 22 April 2021. Downloaded from Association between variability in body mass index and development of type 2 diabetes: Panasonic cohort study Hiroshi Okada ,1 Masahide Hamaguchi ,2 Momoko Habu,1 Kazushiro Kurogi,3 Hiroaki Murata,4 Masato Ito,3 Michiaki Fukui2 To cite: Okada H, ABSTRACT Hamaguchi M, Habu M, Introduction Contrasting results have been reported for Significance of this study et al. Association between the association between the variability in body weight variability in body mass index and development of diabetes. In the present study, we What is already known about this subject? and development of type 2 evaluated the association between the variability in body ► Obesity or body weight gain accelerate the develop- diabetes: Panasonic cohort ment of diabetes. study. BMJ Open Diab Res Care mass index (BMI) and development of type 2 diabetes in 19 412 Japanese participants without obesity and without ► The association between the variability in body 2021;9:e002123. doi:10.1136/ weight and development of diabetes is controversial. bmjdrc-2021-002123 body weight gain or loss during the study period. Research design and methods We recorded body weight What are the new findings? of the participants consecutively each year in Panasonic ► The risk for developing diabetes increased by 11.1% Received 9 January 2021 Corporation, Osaka, Japan from 2008 to 2014 to evaluate Revised 26 February 2021 per 1% increase in coefficient of variation of body the variability of BMI. The participants with obesity (BMI mass index (BMI).
    [Show full text]